| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRNS | Common Stock | Sale | -$118K | -11.9K | -5.03% | $9.94 | 224K | Feb 16, 2024 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the "Company") sold by the reporting person pursuant to a Rule 10b5-1 Plan adopted on May 16, 2022 to cover tax obligations in connection with the vesting of restricted stock units. |
| F2 | The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $9.88 to $9.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. |